|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||13.21 - 13.39|
|52-week range||11.65 - 17.34|
|Beta (5Y monthly)||1.33|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||0.59 (4.41%)|
|Ex-dividend date||28 Apr 2021|
|1y target est||15.30|
LEVERKUSEN, Germany & EMERYVILLE, Calif., September 14, 2021--Leaps by Bayer, the impact investment arm of Bayer AG, today announced that it has co-led a USD 15 million Series A investment round in agriculture and biotechnology innovator, Andes, with Cavallo Ventures. Other new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini participated, alongside existing investors KdT Ventures and Endurance.
(Bloomberg) -- Bayer AG just made its second investment in as many months in startups working to curb the use of synthetic fertilizers, a step that would help the agricultural industry -- a major polluter -- become more environmentally friendly.The industry giant, which owns agrochemical and biotechnology company Monsanto Co., said Tuesday one of its units co-lead a $15 million investment in Andes, a startup that treats seeds so plants can better draw nitrogen from the air instead of needing ene
Bayer (BAYRY) posts positive data from the phase IIb PAGANINI study which is evaluating its investigational candidate, eliapixant, in patients with refractory chronic cough.